1 Introduction to Research & Analysis Reports
1.1 Oxidized Regenerated Cellulose Hemostatic Agent Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oxidized Regenerated Cellulose Hemostatic Agent Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oxidized Regenerated Cellulose Hemostatic Agent Overall Market Size
2.1 Global Oxidized Regenerated Cellulose Hemostatic Agent Market Size: 2022 VS 2029
2.2 Global Oxidized Regenerated Cellulose Hemostatic Agent Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Oxidized Regenerated Cellulose Hemostatic Agent Sales: 2018-2029
3 Company Landscape
3.1 Top Oxidized Regenerated Cellulose Hemostatic Agent Players in Global Market
3.2 Top Global Oxidized Regenerated Cellulose Hemostatic Agent Companies Ranked by Revenue
3.3 Global Oxidized Regenerated Cellulose Hemostatic Agent Revenue by Companies
3.4 Global Oxidized Regenerated Cellulose Hemostatic Agent Sales by Companies
3.5 Global Oxidized Regenerated Cellulose Hemostatic Agent Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Oxidized Regenerated Cellulose Hemostatic Agent Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Oxidized Regenerated Cellulose Hemostatic Agent Product Type
3.8 Tier 1, Tier 2 and Tier 3 Oxidized Regenerated Cellulose Hemostatic Agent Players in Global Market
3.8.1 List of Global Tier 1 Oxidized Regenerated Cellulose Hemostatic Agent Companies
3.8.2 List of Global Tier 2 and Tier 3 Oxidized Regenerated Cellulose Hemostatic Agent Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Oxidized Regenerated Cellulose Hemostatic Agent Market Size Markets, 2022 & 2029
4.1.2 Absorbable
4.1.3 Non-absorbable
4.2 By Type – Global Oxidized Regenerated Cellulose Hemostatic Agent Revenue & Forecasts
4.2.1 By Type – Global Oxidized Regenerated Cellulose Hemostatic Agent Revenue, 2018-2023
4.2.2 By Type – Global Oxidized Regenerated Cellulose Hemostatic Agent Revenue, 2024-2029
4.2.3 By Type – Global Oxidized Regenerated Cellulose Hemostatic Agent Revenue Market Share, 2018-2029
4.3 By Type – Global Oxidized Regenerated Cellulose Hemostatic Agent Sales & Forecasts
4.3.1 By Type – Global Oxidized Regenerated Cellulose Hemostatic Agent Sales, 2018-2023
4.3.2 By Type – Global Oxidized Regenerated Cellulose Hemostatic Agent Sales, 2024-2029
4.3.3 By Type – Global Oxidized Regenerated Cellulose Hemostatic Agent Sales Market Share, 2018-2029
4.4 By Type – Global Oxidized Regenerated Cellulose Hemostatic Agent Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Oxidized Regenerated Cellulose Hemostatic Agent Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application – Global Oxidized Regenerated Cellulose Hemostatic Agent Revenue & Forecasts
5.2.1 By Application – Global Oxidized Regenerated Cellulose Hemostatic Agent Revenue, 2018-2023
5.2.2 By Application – Global Oxidized Regenerated Cellulose Hemostatic Agent Revenue, 2024-2029
5.2.3 By Application – Global Oxidized Regenerated Cellulose Hemostatic Agent Revenue Market Share, 2018-2029
5.3 By Application – Global Oxidized Regenerated Cellulose Hemostatic Agent Sales & Forecasts
5.3.1 By Application – Global Oxidized Regenerated Cellulose Hemostatic Agent Sales, 2018-2023
5.3.2 By Application – Global Oxidized Regenerated Cellulose Hemostatic Agent Sales, 2024-2029
5.3.3 By Application – Global Oxidized Regenerated Cellulose Hemostatic Agent Sales Market Share, 2018-2029
5.4 By Application – Global Oxidized Regenerated Cellulose Hemostatic Agent Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Oxidized Regenerated Cellulose Hemostatic Agent Market Size, 2022 & 2029
6.2 By Region – Global Oxidized Regenerated Cellulose Hemostatic Agent Revenue & Forecasts
6.2.1 By Region – Global Oxidized Regenerated Cellulose Hemostatic Agent Revenue, 2018-2023
6.2.2 By Region – Global Oxidized Regenerated Cellulose Hemostatic Agent Revenue, 2024-2029
6.2.3 By Region – Global Oxidized Regenerated Cellulose Hemostatic Agent Revenue Market Share, 2018-2029
6.3 By Region – Global Oxidized Regenerated Cellulose Hemostatic Agent Sales & Forecasts
6.3.1 By Region – Global Oxidized Regenerated Cellulose Hemostatic Agent Sales, 2018-2023
6.3.2 By Region – Global Oxidized Regenerated Cellulose Hemostatic Agent Sales, 2024-2029
6.3.3 By Region – Global Oxidized Regenerated Cellulose Hemostatic Agent Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Oxidized Regenerated Cellulose Hemostatic Agent Revenue, 2018-2029
6.4.2 By Country – North America Oxidized Regenerated Cellulose Hemostatic Agent Sales, 2018-2029
6.4.3 US Oxidized Regenerated Cellulose Hemostatic Agent Market Size, 2018-2029
6.4.4 Canada Oxidized Regenerated Cellulose Hemostatic Agent Market Size, 2018-2029
6.4.5 Mexico Oxidized Regenerated Cellulose Hemostatic Agent Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Oxidized Regenerated Cellulose Hemostatic Agent Revenue, 2018-2029
6.5.2 By Country – Europe Oxidized Regenerated Cellulose Hemostatic Agent Sales, 2018-2029
6.5.3 Germany Oxidized Regenerated Cellulose Hemostatic Agent Market Size, 2018-2029
6.5.4 France Oxidized Regenerated Cellulose Hemostatic Agent Market Size, 2018-2029
6.5.5 U.K. Oxidized Regenerated Cellulose Hemostatic Agent Market Size, 2018-2029
6.5.6 Italy Oxidized Regenerated Cellulose Hemostatic Agent Market Size, 2018-2029
6.5.7 Russia Oxidized Regenerated Cellulose Hemostatic Agent Market Size, 2018-2029
6.5.8 Nordic Countries Oxidized Regenerated Cellulose Hemostatic Agent Market Size, 2018-2029
6.5.9 Benelux Oxidized Regenerated Cellulose Hemostatic Agent Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Oxidized Regenerated Cellulose Hemostatic Agent Revenue, 2018-2029
6.6.2 By Region – Asia Oxidized Regenerated Cellulose Hemostatic Agent Sales, 2018-2029
6.6.3 China Oxidized Regenerated Cellulose Hemostatic Agent Market Size, 2018-2029
6.6.4 Japan Oxidized Regenerated Cellulose Hemostatic Agent Market Size, 2018-2029
6.6.5 South Korea Oxidized Regenerated Cellulose Hemostatic Agent Market Size, 2018-2029
6.6.6 Southeast Asia Oxidized Regenerated Cellulose Hemostatic Agent Market Size, 2018-2029
6.6.7 India Oxidized Regenerated Cellulose Hemostatic Agent Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Oxidized Regenerated Cellulose Hemostatic Agent Revenue, 2018-2029
6.7.2 By Country – South America Oxidized Regenerated Cellulose Hemostatic Agent Sales, 2018-2029
6.7.3 Brazil Oxidized Regenerated Cellulose Hemostatic Agent Market Size, 2018-2029
6.7.4 Argentina Oxidized Regenerated Cellulose Hemostatic Agent Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Oxidized Regenerated Cellulose Hemostatic Agent Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Oxidized Regenerated Cellulose Hemostatic Agent Sales, 2018-2029
6.8.3 Turkey Oxidized Regenerated Cellulose Hemostatic Agent Market Size, 2018-2029
6.8.4 Israel Oxidized Regenerated Cellulose Hemostatic Agent Market Size, 2018-2029
6.8.5 Saudi Arabia Oxidized Regenerated Cellulose Hemostatic Agent Market Size, 2018-2029
6.8.6 UAE Oxidized Regenerated Cellulose Hemostatic Agent Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 B. Braun
7.1.1 B. Braun Company Summary
7.1.2 B. Braun Business Overview
7.1.3 B. Braun Oxidized Regenerated Cellulose Hemostatic Agent Major Product Offerings
7.1.4 B. Braun Oxidized Regenerated Cellulose Hemostatic Agent Sales and Revenue in Global (2018-2023)
7.1.5 B. Braun Key News & Latest Developments
7.2 OKCEL
7.2.1 OKCEL Company Summary
7.2.2 OKCEL Business Overview
7.2.3 OKCEL Oxidized Regenerated Cellulose Hemostatic Agent Major Product Offerings
7.2.4 OKCEL Oxidized Regenerated Cellulose Hemostatic Agent Sales and Revenue in Global (2018-2023)
7.2.5 OKCEL Key News & Latest Developments
7.3 Emosist
7.3.1 Emosist Company Summary
7.3.2 Emosist Business Overview
7.3.3 Emosist Oxidized Regenerated Cellulose Hemostatic Agent Major Product Offerings
7.3.4 Emosist Oxidized Regenerated Cellulose Hemostatic Agent Sales and Revenue in Global (2018-2023)
7.3.5 Emosist Key News & Latest Developments
7.4 Altaylar Medikal
7.4.1 Altaylar Medikal Company Summary
7.4.2 Altaylar Medikal Business Overview
7.4.3 Altaylar Medikal Oxidized Regenerated Cellulose Hemostatic Agent Major Product Offerings
7.4.4 Altaylar Medikal Oxidized Regenerated Cellulose Hemostatic Agent Sales and Revenue in Global (2018-2023)
7.4.5 Altaylar Medikal Key News & Latest Developments
7.5 Cura Medical
7.5.1 Cura Medical Company Summary
7.5.2 Cura Medical Business Overview
7.5.3 Cura Medical Oxidized Regenerated Cellulose Hemostatic Agent Major Product Offerings
7.5.4 Cura Medical Oxidized Regenerated Cellulose Hemostatic Agent Sales and Revenue in Global (2018-2023)
7.5.5 Cura Medical Key News & Latest Developments
7.6 MDD Sp. z o.o.
7.6.1 MDD Sp. z o.o. Company Summary
7.6.2 MDD Sp. z o.o. Business Overview
7.6.3 MDD Sp. z o.o. Oxidized Regenerated Cellulose Hemostatic Agent Major Product Offerings
7.6.4 MDD Sp. z o.o. Oxidized Regenerated Cellulose Hemostatic Agent Sales and Revenue in Global (2018-2023)
7.6.5 MDD Sp. z o.o. Key News & Latest Developments
7.7 Gelita Medical
7.7.1 Gelita Medical Company Summary
7.7.2 Gelita Medical Business Overview
7.7.3 Gelita Medical Oxidized Regenerated Cellulose Hemostatic Agent Major Product Offerings
7.7.4 Gelita Medical Oxidized Regenerated Cellulose Hemostatic Agent Sales and Revenue in Global (2018-2023)
7.7.5 Gelita Medical Key News & Latest Developments
7.8 Betatech Medical
7.8.1 Betatech Medical Company Summary
7.8.2 Betatech Medical Business Overview
7.8.3 Betatech Medical Oxidized Regenerated Cellulose Hemostatic Agent Major Product Offerings
7.8.4 Betatech Medical Oxidized Regenerated Cellulose Hemostatic Agent Sales and Revenue in Global (2018-2023)
7.8.5 Betatech Medical Key News & Latest Developments
7.9 MERIZELLE
7.9.1 MERIZELLE Company Summary
7.9.2 MERIZELLE Business Overview
7.9.3 MERIZELLE Oxidized Regenerated Cellulose Hemostatic Agent Major Product Offerings
7.9.4 MERIZELLE Oxidized Regenerated Cellulose Hemostatic Agent Sales and Revenue in Global (2018-2023)
7.9.5 MERIZELLE Key News & Latest Developments
7.10 Baxter
7.10.1 Baxter Company Summary
7.10.2 Baxter Business Overview
7.10.3 Baxter Oxidized Regenerated Cellulose Hemostatic Agent Major Product Offerings
7.10.4 Baxter Oxidized Regenerated Cellulose Hemostatic Agent Sales and Revenue in Global (2018-2023)
7.10.5 Baxter Key News & Latest Developments
7.11 Aegis Lifesciences
7.11.1 Aegis Lifesciences Company Summary
7.11.2 Aegis Lifesciences Oxidized Regenerated Cellulose Hemostatic Agent Business Overview
7.11.3 Aegis Lifesciences Oxidized Regenerated Cellulose Hemostatic Agent Major Product Offerings
7.11.4 Aegis Lifesciences Oxidized Regenerated Cellulose Hemostatic Agent Sales and Revenue in Global (2018-2023)
7.11.5 Aegis Lifesciences Key News & Latest Developments
7.12 Boz Medical
7.12.1 Boz Medical Company Summary
7.12.2 Boz Medical Oxidized Regenerated Cellulose Hemostatic Agent Business Overview
7.12.3 Boz Medical Oxidized Regenerated Cellulose Hemostatic Agent Major Product Offerings
7.12.4 Boz Medical Oxidized Regenerated Cellulose Hemostatic Agent Sales and Revenue in Global (2018-2023)
7.12.5 Boz Medical Key News & Latest Developments
7.13 Will-Pharma
7.13.1 Will-Pharma Company Summary
7.13.2 Will-Pharma Oxidized Regenerated Cellulose Hemostatic Agent Business Overview
7.13.3 Will-Pharma Oxidized Regenerated Cellulose Hemostatic Agent Major Product Offerings
7.13.4 Will-Pharma Oxidized Regenerated Cellulose Hemostatic Agent Sales and Revenue in Global (2018-2023)
7.13.5 Will-Pharma Key News & Latest Developments
7.14 Healthium Medtech
7.14.1 Healthium Medtech Company Summary
7.14.2 Healthium Medtech Business Overview
7.14.3 Healthium Medtech Oxidized Regenerated Cellulose Hemostatic Agent Major Product Offerings
7.14.4 Healthium Medtech Oxidized Regenerated Cellulose Hemostatic Agent Sales and Revenue in Global (2018-2023)
7.14.5 Healthium Medtech Key News & Latest Developments
7.15 J&J MedTech
7.15.1 J&J MedTech Company Summary
7.15.2 J&J MedTech Business Overview
7.15.3 J&J MedTech Oxidized Regenerated Cellulose Hemostatic Agent Major Product Offerings
7.15.4 J&J MedTech Oxidized Regenerated Cellulose Hemostatic Agent Sales and Revenue in Global (2018-2023)
7.15.5 J&J MedTech Key News & Latest Developments
7.16 Symatese
7.16.1 Symatese Company Summary
7.16.2 Symatese Business Overview
7.16.3 Symatese Oxidized Regenerated Cellulose Hemostatic Agent Major Product Offerings
7.16.4 Symatese Oxidized Regenerated Cellulose Hemostatic Agent Sales and Revenue in Global (2018-2023)
7.16.5 Symatese Key News & Latest Developments
7.17 Medprin Regenerative Medical Technologies
7.17.1 Medprin Regenerative Medical Technologies Company Summary
7.17.2 Medprin Regenerative Medical Technologies Business Overview
7.17.3 Medprin Regenerative Medical Technologies Oxidized Regenerated Cellulose Hemostatic Agent Major Product Offerings
7.17.4 Medprin Regenerative Medical Technologies Oxidized Regenerated Cellulose Hemostatic Agent Sales and Revenue in Global (2018-2023)
7.17.5 Medprin Regenerative Medical Technologies Key News & Latest Developments
8 Global Oxidized Regenerated Cellulose Hemostatic Agent Production Capacity, Analysis
8.1 Global Oxidized Regenerated Cellulose Hemostatic Agent Production Capacity, 2018-2029
8.2 Oxidized Regenerated Cellulose Hemostatic Agent Production Capacity of Key Manufacturers in Global Market
8.3 Global Oxidized Regenerated Cellulose Hemostatic Agent Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Oxidized Regenerated Cellulose Hemostatic Agent Supply Chain Analysis
10.1 Oxidized Regenerated Cellulose Hemostatic Agent Industry Value Chain
10.2 Oxidized Regenerated Cellulose Hemostatic Agent Upstream Market
10.3 Oxidized Regenerated Cellulose Hemostatic Agent Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Oxidized Regenerated Cellulose Hemostatic Agent Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界の酸化再生セルロース止血剤市場予測2023-2029：吸収性、非吸収性 |
| 【英語タイトル】Oxidized Regenerated Cellulose Hemostatic Agent Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5866 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：114 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥481,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥625,300 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥721,500 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の酸化再生セルロース止血剤市場規模と予測を収録しています。・世界の酸化再生セルロース止血剤市場：売上、2018年-2023年、2024年-2029年 ・世界の酸化再生セルロース止血剤市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の酸化再生セルロース止血剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「吸収性」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 酸化再生セルロース止血剤のグローバル主要企業は、B. Braun、 OKCEL、 Emosist、 Altaylar Medikal、 Cura Medical、 MDD Sp. z o.o.、 Gelita Medical、 Betatech Medical、 MERIZELLE、 Baxter、 Aegis Lifesciences、 Boz Medical、 Will-Pharma、 Healthium Medtech、 J&J MedTech、 Symatese、 Medprin Regenerative Medical Technologiesなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、酸化再生セルロース止血剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の酸化再生セルロース止血剤市場：タイプ別、2018年-2023年、2024年-2029年 世界の酸化再生セルロース止血剤市場：タイプ別市場シェア、2022年 ・吸収性、非吸収性 世界の酸化再生セルロース止血剤市場：用途別、2018年-2023年、2024年-2029年 世界の酸化再生セルロース止血剤市場：用途別市場シェア、2022年 ・病院、診療所、その他 世界の酸化再生セルロース止血剤市場：地域・国別、2018年-2023年、2024年-2029年 世界の酸化再生セルロース止血剤市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における酸化再生セルロース止血剤のグローバル売上、2018年-2023年 ・主要企業における酸化再生セルロース止血剤のグローバル売上シェア、2022年 ・主要企業における酸化再生セルロース止血剤のグローバル販売量、2018年-2023年 ・主要企業における酸化再生セルロース止血剤のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 B. Braun、 OKCEL、 Emosist、 Altaylar Medikal、 Cura Medical、 MDD Sp. z o.o.、 Gelita Medical、 Betatech Medical、 MERIZELLE、 Baxter、 Aegis Lifesciences、 Boz Medical、 Will-Pharma、 Healthium Medtech、 J&J MedTech、 Symatese、 Medprin Regenerative Medical Technologies ************************************************************* ・調査・分析レポートの概要 酸化再生セルロース止血剤市場の定義 市場セグメント 世界の酸化再生セルロース止血剤市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の酸化再生セルロース止血剤市場規模 世界の酸化再生セルロース止血剤市場規模：2022年 VS 2029年 世界の酸化再生セルロース止血剤市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの酸化再生セルロース止血剤の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の酸化再生セルロース止血剤製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：吸収性、非吸収性 酸化再生セルロース止血剤のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、診療所、その他 酸化再生セルロース止血剤の用途別グローバル売上・予測 ・地域別市場分析 地域別酸化再生セルロース止血剤市場規模 2022年と2029年 地域別酸化再生セルロース止血剤売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） B. Braun、 OKCEL、 Emosist、 Altaylar Medikal、 Cura Medical、 MDD Sp. z o.o.、 Gelita Medical、 Betatech Medical、 MERIZELLE、 Baxter、 Aegis Lifesciences、 Boz Medical、 Will-Pharma、 Healthium Medtech、 J&J MedTech、 Symatese、 Medprin Regenerative Medical Technologies ... |
Oxidized regenerated cellulose is a sterile absorbable fibrous biomaterial that has become a major local hemostatic agent thanks to its ease of use, favorable biocompatibility and bioabsorption characteristics.
This report aims to provide a comprehensive presentation of the global market for Oxidized Regenerated Cellulose Hemostatic Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oxidized Regenerated Cellulose Hemostatic Agent. This report contains market size and forecasts of Oxidized Regenerated Cellulose Hemostatic Agent in global, including the following market information:
Global Oxidized Regenerated Cellulose Hemostatic Agent Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Oxidized Regenerated Cellulose Hemostatic Agent Market Sales, 2018-2023, 2024-2029, (Tons)
Global top five Oxidized Regenerated Cellulose Hemostatic Agent companies in 2022 (%)
The global Oxidized Regenerated Cellulose Hemostatic Agent market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Absorbable Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Oxidized Regenerated Cellulose Hemostatic Agent include B. Braun, OKCEL, Emosist, Altaylar Medikal, Cura Medical, MDD Sp. z o.o., Gelita Medical, Betatech Medical and MERIZELLE, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oxidized Regenerated Cellulose Hemostatic Agent manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oxidized Regenerated Cellulose Hemostatic Agent Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Oxidized Regenerated Cellulose Hemostatic Agent Market Segment Percentages, by Type, 2022 (%)
Absorbable
Non-absorbable
Global Oxidized Regenerated Cellulose Hemostatic Agent Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Oxidized Regenerated Cellulose Hemostatic Agent Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Other
Global Oxidized Regenerated Cellulose Hemostatic Agent Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Oxidized Regenerated Cellulose Hemostatic Agent Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oxidized Regenerated Cellulose Hemostatic Agent revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Oxidized Regenerated Cellulose Hemostatic Agent revenues share in global market, 2022 (%)
Key companies Oxidized Regenerated Cellulose Hemostatic Agent sales in global market, 2018-2023 (Estimated), (Tons)
Key companies Oxidized Regenerated Cellulose Hemostatic Agent sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
B. Braun
OKCEL
Emosist
Altaylar Medikal
Cura Medical
MDD Sp. z o.o.
Gelita Medical
Betatech Medical
MERIZELLE
Baxter
Aegis Lifesciences
Boz Medical
Will-Pharma
Healthium Medtech
J&J MedTech
Symatese
Medprin Regenerative Medical Technologies
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oxidized Regenerated Cellulose Hemostatic Agent, market overview.
Chapter 2: Global Oxidized Regenerated Cellulose Hemostatic Agent market size in revenue and volume.
Chapter 3: Detailed analysis of Oxidized Regenerated Cellulose Hemostatic Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oxidized Regenerated Cellulose Hemostatic Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Oxidized Regenerated Cellulose Hemostatic Agent capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| ★調査レポート[世界の酸化再生セルロース止血剤市場予測2023-2029：吸収性、非吸収性] (コード：MMG23JU5866)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の酸化再生セルロース止血剤市場予測2023-2029：吸収性、非吸収性]についてメールでお問い合わせ |
